Event Details
Dates: May 29 to June 2, 2026
Location: McCormick Place, 2301 S Martin Luther King Dr, Chicago, IL 60616
Event Website: https://www.asco.org/annual-meeting#
Event Overview
Cizzle Bio will attend the 2026 ASCO Annual Meeting, one of the largest and most influential global oncology gatherings organized by the American Society of Clinical Oncology. The meeting brings together clinicians, researchers, and industry leaders from around the world to discuss the latest breakthroughs in cancer research, diagnostics, treatment strategies, and patient care.
The comprehensive program features hundreds of scientific sessions, including plenary presentations, oral abstract sessions, poster discussions, and expert-led symposia. These sessions highlight emerging clinical research, translational science, and innovations shaping the future of oncology.
Why Attend
Gain insight into cutting edge oncology research and clinical discoveries presented by global experts.
Explore advances in diagnostics, biomarker research, precision oncology, and emerging therapies.
Connect with oncology professionals, researchers, and innovators from across the international cancer community.
Participate in one of the largest international forums for collaboration and knowledge sharing in cancer care.
Cizzle Bio’s Focus
As a company dedicated to advancing biomarker blood tests for early cancer detection, Cizzle Bio values opportunities to engage with the global oncology community and stay informed on emerging scientific developments that can improve early diagnosis and patient outcomes.
Cizzle Bio’s commitment to improving cancer outcomes is also reflected in the leadership of our CEO, Bill Behnke, who proudly serves on the board of the Conquer Cancer Foundation®—the charitable arm of the American Society of Clinical Oncology. Through its support of groundbreaking research, global education, and patient-centered initiatives, the Foundation plays a vital role in advancing the fight against cancer worldwide. Bill’s involvement reflects Cizzle Bio’s broader mission to support innovation, collaboration, and progress in cancer research and patient care.
Attendance at the ASCO Annual Meeting supports our commitment to collaboration, innovation, and continued progress in early cancer detection and diagnostic advancement.